Pparδ agonist 5
This compound is a selective, orally bioavailable PPARδ agonist (EC50 = 0.335 μM) with improved selectivity over GW0742. Research indicates it can enhance bone density and microarchitecture in vivo, making it a useful tool for studying metabolic bone disorders and PPARδ signaling in both cellular and animal models.
Product Specifications
Field of Research
Metabolism Research, Molecular Biology, Pharmacology & Drug Discovery
Molecular Formula
C23H21F3N2O2S
Molecular Weight
446.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
